These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5713558)

  • 41. The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1977 Feb; 59(2):311-22. PubMed ID: 837018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
    Boismare F; Moore N; Decourt S; Paux G; Saligaut C; Chretien P
    Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative studies on the beta-adrenolytic effects and effect of beta-receptor blocking substances on heart rate, heart minute volume and heart beat volume].
    Rahn KH; Ockenga T
    Verh Dtsch Ges Inn Med; 1967; 73():587-9. PubMed ID: 5591810
    [No Abstract]   [Full Text] [Related]  

  • 45. Wake up and smell the caffeine.
    Ziegelstein RC
    Am J Cardiol; 2004 Oct; 94(7):981-2. PubMed ID: 15464697
    [No Abstract]   [Full Text] [Related]  

  • 46. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology.
    Fleckenstein A; Janke J; Döring HJ; Leder O
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():563-80. PubMed ID: 4468468
    [No Abstract]   [Full Text] [Related]  

  • 47. [Psychomental stress and cardiovascular reactivity under the action of prenylamine].
    Grünewald R; Bernardo A; Siegrist J
    Fortschr Med; 1985 Sep; 103(36):857-60. PubMed ID: 3908256
    [No Abstract]   [Full Text] [Related]  

  • 48. Investigation of a possible beta-blocking action of prenylamine in man.
    Hodge RL
    Aust J Exp Biol Med Sci; 1969 Oct; 47(5):651-2. PubMed ID: 4392091
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of a CA-antagonist (prenylamine) on isoproterenol-induced myocardial lesions in the monkey (Cebus paraguayenses). Electrocardiographic and anatomopathological findings.
    Milei J; Vazquez A; Bolomo N
    Acta Cardiol; 1979; 34(6):417-29. PubMed ID: 120665
    [No Abstract]   [Full Text] [Related]  

  • 50. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
    Falicov RE; Lipp H; Resnekov L; King S
    Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
    [No Abstract]   [Full Text] [Related]  

  • 52. Protective effect of prenylamine against vulnerability to ventricular fibrillation in the normal and ischemic canine myocardium.
    Schoeneberger AS; Verrier RL; Lown B
    Proc Soc Exp Biol Med; 1979 May; 161(1):56-9. PubMed ID: 441070
    [No Abstract]   [Full Text] [Related]  

  • 53. Action of pharmacologic agents in experimental cardiac tamponade.
    Finegan RE; Schroll M; Robison S; Harrison DC
    Am Heart J; 1971 Feb; 81(2):220-6. PubMed ID: 5539547
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influence of the extracellular hydrogen-ion concentration on the effect of cardiovascular drugs].
    Köhler E; Noack E; Wirth K
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 154(2):165-76. PubMed ID: 5549671
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.
    Lish PM; Shelanski MV; LaBudde JA; Williams WR
    Curr Ther Res Clin Exp; 1967 Jun; 9(6):311-24. PubMed ID: 4963067
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of drugs on pyrocatechinamine metabolism].
    Schmid B; Böhle E; Fengler H; Grobecker H; Güllner H; Helmstaedt D; May B; Moon HK; Palm D; Planz G; Quiring K
    Verh Dtsch Ges Inn Med; 1969; 75():164-6. PubMed ID: 5400112
    [No Abstract]   [Full Text] [Related]  

  • 57. [Central and peripheral action of prenylamine].
    Donnet V; Duflot JC; Jacquin M; Mursasco A; Fornaris M
    C R Seances Soc Biol Fil; 1967; 161(11):2232-5. PubMed ID: 4232251
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-hypertensive action of prenylamine: critical study].
    Donnet V; Duflot JC; Jacquin M; Peyrot J; Pommier De Santi P
    C R Seances Soc Biol Fil; 1967; 161(11):2230-2. PubMed ID: 4232250
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evaluation of the pulse-contour method for the continuous monitoring of the cardiac output in dogs].
    Purschke R; Pütz E; Arndt JO
    Pflugers Arch; 1972; 332():Suppl 332:R50. PubMed ID: 5066038
    [No Abstract]   [Full Text] [Related]  

  • 60. [The relationship of cardiodepressive and adrenolytic effects of various beta-receptor blocking agents on dog heart-lung preparations].
    Schmidt HD; Schmier J
    Klin Wochenschr; 1967 Jul; 45(13):688-90. PubMed ID: 5589240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.